Divi's Laboratories Limited (NSE:DIVISLAB)
India · Delayed Price · Currency is INR 6,403.50
-5.00 (-0.08%)
Mar 2, 2026, 3:30 PM IST
Divi's Laboratories Market Cap
Divi's Laboratories has a market cap or net worth of 1.7 trillion as of March 2, 2026. Its market cap has increased by 4.28% in one year.
Market Cap
1.70T
Enterprise Value
1.67T
Revenue
103.14B
Ranking
n/a
PE Ratio
68.58
Stock Price
6,403.50
Market Cap Chart
Since March 12, 2003, Divi's Laboratories's market cap has increased from 2.04B to 1.70T, an increase of 83,413.37%. That is a compound annual growth rate of 34.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 1.70T | 0.25% |
| Dec 31, 2025 | 1.70T | 4.82% |
| Dec 31, 2024 | 1.62T | 56.22% |
| Dec 29, 2023 | 1.04T | 14.38% |
| Dec 30, 2022 | 906.10B | -27.04% |
| Dec 31, 2021 | 1.24T | 21.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.17T |
| Cipla | 1.09T |
| Mankind Pharma | 927.82B |
| Zydus Lifesciences | 927.45B |
| Aurobindo Pharma | 703.00B |
| Alkem Laboratories | 674.29B |
| Glenmark Pharmaceuticals | 602.98B |
| Laurus Labs | 580.78B |